Literature DB >> 6258789

Presence of steroid receptors in human soft tissue sarcomas of diverse histological origin.

P K Chaudhuri, M J Walker, C W Beattie, T K Das Gupta.   

Abstract

The incidence of cytosol receptors for androgen, estrogen, glucocorticoid, and progesterone was determined in a series of histologically diverse soft tissue sarcomas. Receptor binding was characterized in tumor specimens from 29 adult patients (14 female, 15 male) obtained during surgery. Nineteen (66%) tumor cytosols bound at least one steroid. Seven (24%) had more than one receptor. Ten of 23 (43%) cytosols assayed for androgen binding were positive (Kd 0.97 +/- 0.23 X 10(-9) M; 60.6 +/- 25.9 fmol/mg protein), 7 of 29 (24%) for estrogen (Kd 1.00 +/- 0.19 X 10(-9) M; 33.2 +/- 10.9 fmol/mg protein), 9 of 26 (35%) bound glucocorticoid (Kd 4.22 +/- 1.77 X 10(-9) M; 231.0 +/- 155.0 fmol/mg protein), and 1 of 28 (4%) bound progesterone (Kd 0.41 X 10(-9) M; 18.7 fmol/mg protein). Density gradient analysis suggested that androgen and estrogen binding was located predominantly in the 6S and 7 to 8S regions, respectively, whereas receptor for glucocorticoid sedimented at 8S. Steroid binding was not related to patient age. Estrogen-positive (71%) and glucocorticoid-positive (78%) cytosols appeared predominantly in tumors from female patients. Receptor distribution also appeared to be correlated to tumor histogenetic origin.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 6258789

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  10 in total

1.  Angiosarcoma of the Breast: Immunohistochemical Demonstration of Steroid Receptors and Literature Review.

Authors: 
Journal:  Breast Cancer       Date:  1996-06-28       Impact factor: 4.239

2.  A RASSF1A polymorphism restricts p53/p73 activation and associates with poor survival and accelerated age of onset of soft tissue sarcoma.

Authors:  Karen S Yee; Lukasz Grochola; Garth Hamilton; Anna Grawenda; Elisabeth E Bond; Helge Taubert; Peter Wurl; Gareth L Bond; Eric O'Neill
Journal:  Cancer Res       Date:  2012-03-02       Impact factor: 12.701

3.  Immunohistochemical analysis of desmoid tumours.

Authors:  A Leithner; M Gapp; R Radl; A Pascher; P Krippl; K Leithner; R Windhager; A Beham
Journal:  J Clin Pathol       Date:  2005-11       Impact factor: 3.411

4.  Characterization of malignant mesenchymal cell line (UISO-RS-3) derived from a human rhabdomyosarcoma and inhibition by pharmacologic doses of estrogen.

Authors:  W E Madsen; M J Walker; E A Shaughnessy; J M Brown; T K Das Gupta
Journal:  In Vitro Cell Dev Biol       Date:  1990-10

5.  Androgen-induced cell migration: role of androgen receptor/filamin A association.

Authors:  Gabriella Castoria; Loredana D'Amato; Alessandra Ciociola; Pia Giovannelli; Tiziana Giraldi; Leandra Sepe; Giovanni Paolella; Maria Vittoria Barone; Antimo Migliaccio; Ferdinando Auricchio
Journal:  PLoS One       Date:  2011-02-16       Impact factor: 3.240

6.  Oestrogen and progesterone receptor expression in mammary fibromatosis.

Authors:  S A Rasbridge; C E Gillett; R R Millis
Journal:  J Clin Pathol       Date:  1993-04       Impact factor: 3.411

7.  Steroid receptors in meningiomas. A histochemical and biochemical study.

Authors:  D Hinton; E G Mobbs; A A Sima; W Hanna
Journal:  Acta Neuropathol       Date:  1983       Impact factor: 17.088

8.  Estrogen receptor alpha and androgen receptor are commonly expressed in well-differentiated liposarcoma.

Authors:  Davis R Ingram; Lloye M Dillon; Dina Chelouche Lev; Alexander Lazar; Elizabeth G Demicco; Burton L Eisenberg; Todd W Miller
Journal:  BMC Clin Pathol       Date:  2014-10-22

9.  Expression of human Piwi-like genes is associated with prognosis for soft tissue sarcoma patients.

Authors:  Thomas Greither; Franziska Koser; Matthias Kappler; Matthias Bache; Christine Lautenschläger; Steffen Göbel; Hans-Jürgen Holzhausen; Sven Wach; Peter Würl; Helge Taubert
Journal:  BMC Cancer       Date:  2012-06-29       Impact factor: 4.430

10.  Targeting androgen receptor/Src complex impairs the aggressive phenotype of human fibrosarcoma cells.

Authors:  Gabriella Castoria; Pia Giovannelli; Marzia Di Donato; Ryo Hayashi; Claudio Arra; Ettore Appella; Ferdinando Auricchio; Antimo Migliaccio
Journal:  PLoS One       Date:  2013-10-09       Impact factor: 3.240

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.